Revolutionary Innovations in Diabetes Research: From Biomarkers to Genomic Medicine
نویسندگان
1 Joint International Research Laboratory of Metabolic and Developmental Sciences, Key Laboratory of Urban Agriculture (South) Ministry of Agriculture, Plant Biotechnology Research Center, Fudan-SJTU-Nottingham Plant Biotechnology R&D Center, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
2 Al-Hadi University College, Baghdad, Iraq. Science Faculty, Menoufia University, Menoufia, Egypt. MLS Ministry of Health, Alexandria, Egypt.
3 Al-Hadi University College, Baghdad, Iraq.
4 Science Faculty, Menoufia University, Menoufia, Egypt.
doi
10.18502/ijdo.v15i4.14556چکیده
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia resulting from inadequate insulin signaling. Current management relies on biomarkers such as hemoglobin A1c (HbA1c) to guide therapy, but emerging tools offer opportunities to transform care through more personalized approaches. Molecular biomarkers, including microRNAs, metabolites, and proteins, may enable better prediction ...
